![]() |
市場調查報告書
商品編碼
1800778
2025 年至 2033 年獸醫診斷市場報告(按產品、技術、動物類型、疾病類型、最終用戶和地區)Veterinary Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2025-2033 |
2024年,全球獸醫診斷市場規模達71億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到130億美元,2025-2033年期間的複合年成長率(CAGR)為6.97%。北美憑藉其完善的獸醫基礎設施、日益普及的先進診斷技術以及對動物健康管理的日益重視,佔據了市場主導地位。寵物飼養數量的成長、寵物預防性照護需求的增加,以及人們對可在動物和人類之間傳播的人畜共患疾病的認知不斷提高,是推動市場發展的主要因素。
隨著人們日益認知到動物健康的重要性,及時診斷和疾病預防也日益受到重視。寵物主人、畜牧養殖戶和獸醫專家越來越重視早期發現和定期體檢,以確保動物健康、降低治療費用並提高動物壽命和生產力。此外,政府和業者為加強獸醫衛生系統所採取的措施也鼓勵人們採用診斷方法。促進疾病監測、強制檢測和生物安全的政策強化了診斷在保障公共衛生和動物福利方面的重要性,從而刺激了私人和機構獸醫護理環境的需求。此外,自動化、分子工具和資料分析等診斷技術的不斷進步,大大提高了獸醫檢測的效率、精確度和可靠性。這些進步使得疾病檢測更加準確、流程更加簡化、檢測更加便捷,使診斷成為當代獸醫護理和管理的關鍵要素。
對快速準確測試的需求
獸醫越來越依賴能夠快速且精準地提供結果的診斷工具,以輔助快速做出臨床決策。在病情快速發展的情況下,檢測結果的延遲可能會危及治療效果和動物的康復。對快速診斷結果的需求促使人們創造和使用能夠在照護端或透過快速實驗室處理提供即時資訊的技術。高精度儀器可確保準確的評估,從而減少誤診和多餘程序的可能性。這種對快速性和精準性的關注提高了臨床效率,增強了客戶信任,並促進了患者治療效果的改善。隨著實踐中時間緊迫的狀況日益普遍,不同的獸醫護理環境對能夠提供快速可靠資訊的診斷設備的需求日益成長。 2024 年,碩騰宣佈在全球推出其新型人工智慧血液分析儀 Vetscan OptiCell(TM),該分析儀將於 2025 年 1 月 25 日至 29 日在奧蘭多 VMX 展會上首次亮相。這款無螢幕、基於墨盒的設備結合了黏彈性聚焦和人工智慧,可提供快速、準確的 CBC 結果。
增加獸醫教育和臨床培訓
獸醫教育的發展和對臨床培訓的重視,正在促進診斷技術融入常規獸醫實踐。目前,獸醫學院和培訓中心優先培養診斷工具、實驗室分析和循證治療計劃的實務經驗。這些經驗會影響新手獸醫的期望和臨床行為,因為他們在實踐之初就具備紮實的診斷程序基礎。因此,診斷技術被視為臨床評估和決策的必要工具,而非可有可無。持續教育計畫的不斷湧現也確保了資深從業者能夠及時了解新興技術和診斷方法。這種持續學習的文化提升了診斷技術在獸醫職業中的重要性,並鼓勵人們積極採用創新解決方案。教育體係不斷強調正確檢測的重要性,從而培養了一支更重視診斷的獸醫團隊。
技術創新和診斷進步
臨床生物化學、分子檢測和數位影像等領域的持續進步正在提升診斷能力的準確性、快速性和廣度。這些進步提高了檢測結果的可靠性和精確度,使獸醫能夠做出更明智的臨床決策。此外,與數位平台的整合促進了高效的資料處理、快速的結果分析以及對動物健康狀況的長期監測。此外,自動化和增強的可用性使獸醫從業者能夠更輕鬆地使用診斷工具,有助於高效的實踐管理並提高服務品質。隨著技術的不斷進步,獸醫診斷領域正變得越來越複雜,從而能夠更早地進行干預並提供個人化的護理。順應這一趨勢,Center Point Bio-Tech 於 2024 年在奧蘭多舉辦的 VMX 2024 上推出了其先進的獸醫診斷系統 AlphaION,訂單量超乎預期。 AlphaION 結合了人工智慧、自動化以及表面聲波 (SAW) 測試等創新技術,以擴展臨床診斷能力。它能夠對各種動物物種進行更快、更準確、更經濟的診斷。
擴大動物保健投資和基礎設施
公共和私營部門正在投入更多資源,以加強獸醫基礎設施建設、推動疾病控制措施並提升診斷能力。這體現在現代實驗室的改進、獸醫從業人員教育的提升以及先進檢測設備的廣泛普及。例如,2024年,西孟加拉邦畜牧發展公司在其位於卡爾亞尼的CLART設施推出了一項新的寵物診斷服務。加爾各答及其附近郊區的寵物主人可以在線上預約上門採集樣本,並在政府實驗室進行檢測。該計劃還包括在鹽湖城和巴拉薩特的固定採集點提供免費檢測。強大的基礎設施能夠提高診斷能力、增強服務提供並保證可靠的品質。隨著人們日益認知到動物健康的廣泛影響,尤其是在公共衛生、食品安全和經濟可行性方面,診斷正成為關鍵關注點。
對複雜疾病的早期檢測需求日益成長
隨著人們對動物慢性疾病甚至危及生命的疾病的認知不斷提高,獸醫和寵物主人正在尋求能夠在嚴重臨床症狀出現之前發現異常的診斷方法。先進的檢測儀器使專業人員能夠評估器官功能、識別細胞變化並精準定位指標,從而促進及時、有針對性的干涉。這種快速診斷的趨勢可以提高治療效果、減少侵入性操作並改善動物的生活品質。獸醫護理向主動性和精準導向的轉變凸顯了診斷在臨床過程中的重要性,促進了各種實踐類型中常規和專業檢測服務的持續使用。 2024年,瑪氏科學與診斷公司(Mars Science & Diagnostics)旗下的Antech公司宣佈在北美推出兩項新的獸醫創新技術,包括AIS RapidRead和Nu.Q(R)犬癌症檢測。 AIS RapidRead利用人工智慧提供近乎即時的放射學洞察,而Nu.Q(R)則為犬類提供快速癌症篩檢。這兩種工具都旨在提高診斷速度、準確性和護理效果。
牲畜健康管理日益受到重視
隨著對優質動物性食品的需求不斷成長,生產商正逐步利用診斷解決方案來降低疾病風險、提高繁殖效率並維持合規性。透過診斷進行常規健康評估有助於維護生物安全、最大限度地減少疾病造成的經濟損失並促進永續的農業方法。這使得診斷技術被納入畜群健康計劃,尤其是在商業化養殖實踐中。加強監測和及時發現疾病可以改善準備工作,並減少對緊急護理的依賴。評估畜群整體健康狀況、監測表現指標和識別亞臨床問題的能力正成為生產者的有用資源。隨著全球畜牧業面臨著在不損害動物福利的情況下滿足食品供應需求的壓力,診斷技術作為預防和管理資源的重要性變得越來越重要。
The global veterinary diagnostics market size reached USD 7.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6.97% during 2025-2033. North America dominates the market owing to its well-established veterinary infrastructure, rising adoption of state-of-the-art diagnostic technologies, and an increasing emphasis on animal health management. The growing number of pet ownerships, increasing demand for preventive care of pets, and rising awareness about zoonotic diseases, which can be transmitted between animals and humans, are some of the major factors propelling the market.
The growing acknowledgment of the significance of animal health is resulting in heightened focus on prompt diagnosis and disease prevention. Pet parents, livestock farmers, and veterinary specialists are increasingly prioritizing early detection and regular check-ups to ensure health, lower treatment expenses, and enhance animal longevity and productivity. Moreover, initiatives by both the government and industry to enhance veterinary health systems are encouraging the adoption of diagnostics. Policies that promote disease surveillance, compulsory testing, and biosecurity strengthen the importance of diagnostics in safeguarding public health and animal welfare, catalyzing the demand in both private and institutional veterinary care environments. Apart from this, ongoing advancements in diagnostic techniques, such as automation, molecular tools, and data analysis, are greatly enhancing the efficiency, precision, and dependability of veterinary testing. These advancements allow for more accurate disease detection, streamlined processes, and increased accessibility of tests, positioning diagnostics as a key element of contemporary veterinary care and administration.
Demand for Fast and Accurate Testing
Veterinary practitioners are increasingly depending on diagnostic tools that provide swift and precise results to aid prompt clinical decision-making. In rapidly advancing cases, delays in receiving test results can jeopardize treatment efficacy and animal recuperation. The need for quick diagnostic results is leading to the creation and use of technologies that deliver instant information at the point of care or via expedited lab processing. High-precision instruments guarantee accurate evaluations, decreasing the chances of incorrect diagnoses and superfluous procedures. This focus on promptness and precision boosts clinical productivity, increases client trust, and fosters improved patient results. With ongoing time-sensitive situations in practices, the demand for diagnostics that can provide quick and reliable information is growing within different veterinary care environments. In 2024, Zoetis announced the global launch of its new AI-powered hematology analyzer, Vetscan OptiCell(TM), debuting at VMX in Orlando from January 25-29, 2025. The screenless, cartridge-based device combined viscoelastic focusing and AI to deliver rapid, accurate CBC results.
Increase in Veterinary Education and Clinical Training
The development of veterinary education and the focus on clinical training are facilitating the incorporation of diagnostics into routine veterinary practice. Veterinary colleges and training centers currently prioritize practical experience with diagnostic tools, lab analysis, and evidence-based treatment planning. This exposure influences the expectations and clinical behaviors of novice professionals, who begin their practice with a solid grounding in diagnostic procedures. As a result, diagnostics are considered essential rather than optional tools for clinical assessment and decision-making. The rising availability of continuing education programs also ensures that established practitioners stay informed about emerging technologies and diagnostic methods. This culture of continuous learning enhances the importance of diagnostics in the profession and encourages the embrace of innovative solutions. The educational system, by consistently emphasizing the importance of proper testing, fosters a more diagnostics-focused veterinary workforce.
Technological Innovation and Diagnostic Advancements
Ongoing advancements in fields like clinical biochemistry, molecular testing, and digital imaging are enhancing the accuracy, rapidity, and range of diagnostic abilities. These advancements are improving the dependability and precision of test outcomes, allowing veterinarians to make better-informed clinical choices. Additionally, integration with digital platforms facilitates efficient data handling, quick analysis of results, and improved monitoring of animal health over time. Moreover, automation and enhanced usability are making diagnostic tools more available to veterinary practitioners, aiding in efficient practice management and elevated service quality. With the ongoing advancements in technology, the field of veterinary diagnostics is becoming increasingly complex, allowing for earlier interventions and tailored care. In line with this trend, in 2024, Center Point Bio-Tech launched its advanced veterinary diagnostic system, AlphaION, at VMX 2024 in Orlando, surpassing order expectations. AlphaION combined AI, automation, and innovations like surface acoustic wave (SAW) testing to expand in-clinic diagnostic capabilities. It enabled faster, more accurate, and cost-effective diagnostics for various animal species.
Expanding Animal Health Investments and Infrastructure
The public and private sectors are investing more resources to enhance veterinary infrastructure, advance disease control initiatives, and boost diagnostic capabilities. This is evident in the evolution of contemporary laboratories, improved education for veterinary practitioners, and the broad access to sophisticated testing equipment. For example, in 2024, the West Bengal Livestock Development Corporation launched a new pet diagnostic service at its CLART facility in Kalyani. Pet parents in Kolkata and nearby suburbs could book home sample collections online, with testing conducted at the government lab. The initiative included free testing at static collection points in Salt Lake and Barasat. A robust infrastructure enables increased diagnostic capacity, enhanced service delivery, and reliable quality assurance. With the growing recognition of the wider effects of animal health, particularly regarding public health, food safety, and economic viability, diagnostics are emerging as a key focus.
Rising Need for Early Detection of Complex Conditions
With the growing awareness about chronic and possibly life-threatening conditions in animals, veterinarians and pet parents are pursuing diagnostic options that can detect irregularities prior to the onset of serious clinical symptoms. Sophisticated testing instruments allow professionals to assess organ functionality, recognize cellular modifications, and pinpoint indicators that facilitate prompt, focused interventions. This move towards prompt diagnosis enhances treatment results, reduces invasive procedures, and improves the quality of life for animals. The shift towards proactive and precision-oriented veterinary care highlights the significance of diagnostics in clinical processes, promoting continued use of both routine and specialized testing services in various practice types. In 2024, Antech, part of Mars Science & Diagnostics, announced two new veterinary innovations in North America, including AIS RapidRead and the Nu.Q(R) Canine Cancer Test. AIS RapidRead used AI to deliver near-instant radiology insights, while Nu.Q(R) offered rapid cancer screening for dogs. Both tools aimed to improve diagnostic speed, accuracy, and care outcomes.
Growing Focus on Livestock Health Management
With the rising demand for premium animal-based food products, producers are progressively utilizing diagnostic solutions to mitigate disease risk, improve reproductive efficiency, and maintain regulatory compliance. Routine health evaluations via diagnostics aid in preserving biosecurity, minimizing financial losses from diseases, and promoting sustainable agricultural methods. This is resulting in the incorporation of diagnostics into herd health initiatives, especially in commercial farming practices. Enhanced monitoring and prompt disease detection lead to improved preparation and decreased dependence on urgent care options. The capability to assess general herd health, monitor performance metrics, and identify subclinical issues is emerging as a useful resource for producers. As the global livestock sector faces pressure to satisfy food supply demands without jeopardizing animal welfare, the importance of diagnostics as a preventive and management resource is becoming more vital.
Kits and reagents dominate the market
Kits and reagents play a crucial role in veterinary diagnostics and provide essential tools and substances for conducting various diagnostic tests. They include pre-packaged reagents and instructions for conducting tests, such as enzyme-linked immunosorbent assays (ELISAs) or polymerase chain reaction (PCR) assays. The reagents in these kits are designed to detect specific pathogens or disease markers, allowing veterinarians to diagnose infectious diseases spontaneously and accurately in animals. They are also used to measure parameters, such as complete blood counts, blood chemistries (including liver and kidney function), electrolyte levels, and blood clotting abilities. They assist in detecting abnormalities, such as the presence of bacteria, parasites, blood, or abnormal levels of certain chemicals or metabolites.
Clinical biochemistry holds the largest share in the market
Clinical biochemistry is a fundamental component of veterinary diagnostics that involves the analysis of blood and other body fluids to assess the physiological and biochemical status of animals. It provides valuable information about organ function, metabolic processes, and the presence of diseases or abnormalities. It helps measure a wide range of parameters, including enzymes, electrolytes, proteins, metabolites, hormones, and waste products. It encompasses various tests, which are conducted using specialized laboratory equipment and reagents. It also focuses on providing quantitative data that helps veterinarians in the diagnosis, monitoring, and treatment of various conditions. Furthermore, by evaluating the levels of specific analytes in the blood, such as liver enzymes, kidney function markers (creatinine), glucose, albumin, and electrolytes (sodium and potassium), clinical biochemistry aids in the detection of organ dysfunction, nutritional imbalances, endocrine disorders, and metabolic abnormalities in animals.
Livestock animals hold the maximum share of the market
Livestock animals, such as cattle, pigs, sheep, and poultry, require veterinary diagnostics as it helps identify and diagnose diseases effectively. Early detection is crucial for implementing appropriate control measures to restrict the spread of infectious diseases within herds or flocks. Besides this, diagnostic tests enable veterinarians to accurately identify the causative agents, determine the extent of disease prevalence, and guide the implementation of effective treatment and preventive strategies. Veterinary diagnostic testing also helps assess the health and productivity of individual animals and the overall herd or flock. By monitoring various parameters, such as blood chemistry, fecal quality, and growth rates, veterinarians can identify and address health issues that may affect production efficiency, including nutritional deficiencies, parasitic infections, metabolic disorders, and respiratory diseases.
Non-infectious diseases account for the majority of market share
Veterinary diagnostics play a crucial role in identifying infectious diseases in animals, as accurate and timely diagnosis is essential for appropriate treatment and control measures. It is essential for disease surveillance and monitoring in animal populations. By conducting diagnostic tests on individual animals or within herds or flocks, veterinarians can assess the prevalence, spread, and impact of infectious diseases. It also aids in identifying various zoonotic diseases in animals, helping prevent or minimize the transmission of pathogens from animals to humans. By diagnosing and managing infectious diseases in animals, veterinary diagnostics contribute to protect public health and prevent the spread of zoonotic infections.
Reference laboratories hold the largest share in the market
Reference laboratories play a vital role in veterinary diagnostics by providing specialized and advanced diagnostic services to support veterinarians, clinics, and research institutions. They are equipped with state-of-the-art technology, highly trained personnel, and expertise in a wide range of veterinary diagnostic disciplines. They offer a comprehensive number of diagnostic tests that may not be available at local veterinary clinics or laboratories. They often possess a broader test menu and the capacity to perform essential tests that require specialized equipment, techniques, or expertise. Reference laboratories can perform highly specific and sensitive tests to detect infectious agents, identify genetic disorders, diagnose complex diseases, and assess the overall health status of animals.
North America exhibits a clear dominance, accounting for the largest veterinary diagnostics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the increase in veterinary specialty practices and referral centers. Besides this, the rising focus on pet health and wellness and advanced veterinary medicine is propelling the growth of the market.
Another contributing aspect is the increasing demand for preventive healthcare, early disease detection, and personalized treatment options to ensure their pets lead long and healthy lives is offering a favorable veterinary diagnostics market outlook.
Asia Pacific is estimated to expand further in this domain due to rising adoption of pets among millennials. Besides this, the increasing expansion of livestock and aquaculture industries is bolstering the growth of the market.
Key market players in the market are implementing various strategies and initiatives to improve their business. They are investing in research and development (R&D) activities to innovate and develop new diagnostic technologies, tests, and products. They are also focusing on improving the accuracy, efficiency, and speed of veterinary diagnostic tests, as well as expanding the range of diseases and conditions that can be diagnosed. Top companies are actively pursuing strategic partnerships and acquisitions to expand their product offerings, geographical reach, and market share. They are also providing telemedicine services to pet owners, comprising of consultation, monitoring, and remote diagnostic in certain scenarios. Leading companies are embracing artificial intelligence (AI), machine learning (ML), and molecular diagnostics to improve their product offerings and service delivery.